BR9711329A - Utiliza-Æo de inibidores pkc para a fabrica-Æo de medicamento para tratamento da aids - Google Patents

Utiliza-Æo de inibidores pkc para a fabrica-Æo de medicamento para tratamento da aids

Info

Publication number
BR9711329A
BR9711329A BR9711329A BR9711329A BR9711329A BR 9711329 A BR9711329 A BR 9711329A BR 9711329 A BR9711329 A BR 9711329A BR 9711329 A BR9711329 A BR 9711329A BR 9711329 A BR9711329 A BR 9711329A
Authority
BR
Brazil
Prior art keywords
manufacture
treatment drug
pkc inhibitors
aids treatment
aids
Prior art date
Application number
BR9711329A
Other languages
English (en)
Inventor
Michael R Jirousek
Douglas K Ways
Lawrence E Stramm
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9711329A publication Critical patent/BR9711329A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9711329A 1996-08-30 1997-08-28 Utiliza-Æo de inibidores pkc para a fabrica-Æo de medicamento para tratamento da aids BR9711329A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2487396P 1996-08-30 1996-08-30
US08/917,033 US6107327A (en) 1996-08-30 1997-08-26 Therapeutic treatment for HIV infection
PCT/US1997/015525 WO1998008509A1 (en) 1996-08-30 1997-08-28 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids

Publications (1)

Publication Number Publication Date
BR9711329A true BR9711329A (pt) 1999-08-17

Family

ID=26698971

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711329A BR9711329A (pt) 1996-08-30 1997-08-28 Utiliza-Æo de inibidores pkc para a fabrica-Æo de medicamento para tratamento da aids

Country Status (15)

Country Link
US (1) US6107327A (pt)
EP (1) EP0830860A1 (pt)
JP (1) JP2002514177A (pt)
KR (1) KR20000035861A (pt)
CN (1) CN1228696A (pt)
AU (1) AU4179497A (pt)
BR (1) BR9711329A (pt)
CA (1) CA2263133A1 (pt)
CZ (1) CZ52099A3 (pt)
EA (1) EA199900245A1 (pt)
HU (1) HUP0002531A2 (pt)
IL (1) IL128107A0 (pt)
NO (1) NO990949L (pt)
PL (1) PL331760A1 (pt)
WO (1) WO1998008509A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291446B1 (en) * 1998-03-05 2001-09-18 Eli Lilly And Company Therapeutic treatment for cytomegalovirus infection
US20020107193A1 (en) * 2000-11-09 2002-08-08 Glazner Gordon W. Therapeutic uses for IP3 receptor-mediated calcium channel modulators
JP2003327536A (ja) * 2002-03-07 2003-11-19 Kitasato Inst:The ヒト免疫不全症候群ウイルスの感染、増殖抑制剤
US20040175384A1 (en) * 2003-12-12 2004-09-09 Mohapatra Shyam S. Protein kinase C as a target for the treatment of respiratory syncytial virus
US8592368B2 (en) 2003-12-19 2013-11-26 University Of South Florida JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection
EP2177510A1 (en) 2008-10-17 2010-04-21 Universität des Saarlandes Allosteric protein kinase modulators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
PH27309A (en) * 1989-11-13 1993-05-28 Merrell Dow Pharma Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones
US5516775A (en) * 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
WO1995005824A1 (en) * 1993-08-24 1995-03-02 Smithkline Beecham Corporation Aaptamines and method of use thereof
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
ES2134910T3 (es) * 1993-12-07 1999-10-16 Lilly Co Eli Sintesis de bisindolilmaleimidas.
ES2162843T3 (es) * 1993-12-07 2002-01-16 Lilly Co Eli Inhibidores de la proteina quinasa c.
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors

Also Published As

Publication number Publication date
PL331760A1 (en) 1999-08-02
IL128107A0 (en) 1999-11-30
KR20000035861A (ko) 2000-06-26
JP2002514177A (ja) 2002-05-14
CZ52099A3 (cs) 1999-10-13
EA199900245A1 (ru) 1999-08-26
NO990949D0 (no) 1999-02-26
CA2263133A1 (en) 1998-03-05
US6107327A (en) 2000-08-22
EP0830860A1 (en) 1998-03-25
WO1998008509A1 (en) 1998-03-05
CN1228696A (zh) 1999-09-15
NO990949L (no) 1999-02-26
AU4179497A (en) 1998-03-19
HUP0002531A2 (hu) 2001-02-28

Similar Documents

Publication Publication Date Title
PT1147083E (pt) Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
PT1002795E (pt) Pirimidinas inibidoras da replicacao do hiv
NL300179I2 (nl) Geneesmiddelvoorlopers van trombineremmers.
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
ATE258928T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
ATE259796T1 (de) Respiratorisches syncytialvirus replikation inhibitoren
BR9708528A (pt) Terapia com libertação uniforme de droga
NO20022645L (no) Farmasöytisk superdisintegrerende stoff
PT1206436E (pt) Retinoides para o tratamento de enfisema
NO20005179D0 (no) Medikament behandling
PT777457E (pt) A utilizacao de triacetato de glicerilo para o tratamento de onicomicoses
NO20012976L (no) Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
PT983275E (pt) Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes
BR9711329A (pt) Utiliza-Æo de inibidores pkc para a fabrica-Æo de medicamento para tratamento da aids
PT1089965E (pt) Derivados de ureia para tratamento da dor
PT1051172E (pt) Metodo para tratamento da dpco
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
AU3071999A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases
ID24922A (id) Terapi kombinasi untuk pengobatan aids
AU3071799A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection
BR9711366A (pt) Uso de inibidores pkc para a fabrica-Æo de um medicamento para o tratamento de infec-{es por htvl-1
ITLT940001V0 (it) Pareggiatore ortopedico per invalidi temporanei.
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
SI0829262T1 (en) Use of PKC inhibitors for the manufacture of a medicament for the treatment of sexual dysfunctions

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]